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ABSTRACT 
Objectives: To quantitate and analyze casein and gluten-degrading protease activities 
produced by natural inhabitant oral microorganisms in human saliva, and to isolate new 
gluten-degrading oral species. 
Methods: Whole saliva samples were collected from visitors to the Museum of Science 
in Boston, MA. At total of  769 samples were collected and sample number, subject age, 
race, gender and dietary habits with regard to gluten consumption were reported.  At least 
1 ml of saliva was collected from each subject and the samples were aliquoted into 
several 150 µl aliquots. To one of the aliquots 150 µl 80% BHI/20% glycerol was added 
to preserve the microbes. Enzyme activity analysis was conducted on pre-cast casein and 
zymogram gels. After electrophoresis, gels were renatured and developed, and enzyme 
activities were visualized and analyzed. Protease activity in each sample was evident 
from well-defined bands in the gels resulting from casein digestion. Enzyme activities 
were quantitated within the 75-150 kDa region and compared among subjects. Based on 
this value, subjects were grouped into displaying high, medium, low or negligible 
enzyme activity. Lastly, saliva aliquots from four selected subjects were plated for 
bacteria isolation and characterization of enzyme activities on a gliadin zymogram gel.   
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Results: The average overall salivary enzymatic activity among the various race groups 
was in the order of other/mixed race > Caucasian > Asian > African American > 
Hispanics, where  the Other/mixed race group showed statistically significantly higher 
values than any of the other race groups. With respect to age, the overall enzymatic 
activity was in the order of 7-12 > 31-54 > 55-80 > 13-18 > 19-30 age group. As for the 
gender groups, no statistically significant differences were found in activities between 
males and females. A good consistency was observed in banding patterns between saliva 
samples analyzed on a casein zymogram and a gliadin zymogram gel, indicating that the 
same enzymes act on both substrates. From four selected donors showing unusual and/or 
high salivary enzyme activities, 12-15 individual salivary bacterial strains were cultured 
to purity, and analyzed individually on a zymogram gel. Among these, some showed 
proteolytic activity ~75 kDa, and were suspected to be Rothia bacteria based on previous 
studies. Others showed activity in high or low MW regions indicating different and 
potentially novel species of oral gluten degrading bacteria. 
Conclusion: This large scale study has provided insights into the extent and inter-subject 
variation of salivary enzyme activities, and the apparent molecular weights of the major 
enzymes involved. It furthermore showed conclusively that gliadin-degrading enzyme 
activity is present in saliva, and that casein is a good substitute substrate for investigating 
such activities. Novel gluten-degrading oral species were isolated. Their enzymes could 
potentially be further explored for aiding in the digestion of gluten in vivo as a means to 
treat patients suffering from gluten-intolerance disorders. 
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CHAPTER ONE: INTRODUCTION 
1. Saliva 
        a) Overview 
Saliva is a remarkably complex fluid with numerous important properties and functions 
that are essential for both oral and general health. Human saliva is produced by a unique 
salivary gland system, which is divided into two divisions; the major salivary glands that 
include the parotid, submandibular, and sublingual glands, and the minor salivary glands 
which comprise small glands in the mucosa lining the oral cavity. Salivary secretion is 
controlled by both divisions of the autonomic nervous system, the sympathetic and the 
parasympathetic division. The parotid salivary glands receive parasympathetic 
innervation from the glossopharyngeal nerve, while both the submandibular and 
sublingual glands receive innervations from both the facial and the lingual nerve 
(Holsinger and Bui, 2007). Histologically, the salivary glands are composed of two types 
of epithelial cells: the acinar end-pieces, which secrete most of the salivary proteins in 
addition to the salivary fluid, and the ductal cells which secrete some of the salivary 
proteins but mainly modify the ionic concentration of the final saliva before it is secreted 
into the oral cavity (Holsinger and Bui, 2007). Even though the composition of saliva 
differs among the three major salivary glands, the mechanism of secretion is quite 
similar. Saliva production involves two stages: 
1) Primary saliva, an isotonic plasma-like secretion, is produced by the acinar cells of the 
salivary glands.  
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2) Final hypotonic saliva, which is formed after reabsorption of NaCl and the secretion of 
K+ and HCO3− in the poor water-permeable epithelium of the glandular ducts (Holsinger 
and Bui, 2007). 
        b) Salivary Composition  
Saliva comprises mainly a mixture of organic and inorganic constituents that together 
contribute to the unique composition of saliva. The inorganic components include; Na+ 
and Cl− ions which facilitate the tasting sensation. Bicarbonate ions are essential for the 
buffering action. Calcium and phosphate ions are important for the maintenance of the 
integrity of the intra-oral mineralized tissue structures by keeping the balance between 
de- and re- mineralization with respect to the hydroxyapatite structure of tooth enamel. 
The organic components mainly consist of salivary proteins and peptides. Many of these 
proteins are proline-rich proteins (PRP), which accounts for about 70% of the total 
organic components secreted by the parotid gland. Amylase is the second most common 
protein found in parotid saliva (Dodds et al., 2005). Other major proteins are lysozyme, 
statherin, histatin, mucin, lactoferrin, lingual lipase, peroxide and secretory IgA. Saliva 
also contains the organic blood group antigens A, B, AB, and O expressed on 
glycosylated proteins (Helmerhorst and Oppenheim, 2007). 
        c) Salivary protein synthesis and secretion 
With mass spectrometric approaches, more than 2000 different proteins and peptides 
have been identified in whole saliva. Saliva contains about 1- 4 mg/ml protein, 
considerably less than the total concentration of protein found in plasma, which is about 
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70 mg/ml. There are four phases the salivary proteins go through from synthesis to final 
secretion that have significant effects on protein structure and function:  
Phase 1: Protein synthesis occurs according to its genetic expression from a specific gene 
encoded within the salivary glands.  
Phase 2: Intracellular post-translational protein modifications occur prior to secretion, 
including glycosylation, phosphorylation, and proteolytic processing.  
Phase 3: Proteins are further altered during the passage through the ductal system.  
Phase 4: Post-secretory changes and proteolytic degradations occur when the glandular 
proteins come in contact with non-sterile whole saliva that contains mixtures of enzymes 
derived from various sources (Helmerhorst and Oppenheim, 2007). 
Several of the major salivary protein families are discussed below. 
Histatins 
Histatins 1, 3, and 5 are small molecular weight proteins ranging from 3-5 kDa in size 
and contain 38, 32, and 24 amino acid residues, respectively. They comprise a family of 
isoforms that are encoded by two genes, HIS1 and HIS2 (Troxler et al., 1990). They are 
secreted by the parotid and submandibular glands, and are only found in human saliva 
fluid and not in other mammalian body fluids (Baum et al., 1976)  Their concentration is 
lower in whole saliva compared to the concentration within glandular secretions which is 
due to extensive proteolytic degradation upon their release into the oral cavity 
(Helmerhorst et al., 2006). Histatin 1 is neutral in charge while both histatin 3 and 5 are 
basic (Oppenheim et al., 1988).  They possess an important biological role in the defense 
mechanism against Candida infections by inhibiting the growth of the yeast Candida 
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albicans, and also exhibit an antimicrobial activity by inhibiting a variety of bacterial and 
host proteases and toxins (Helmerhorst et al., 2001). 
Statherin 
Statherin is a small molecular weight protein rich in the amino acids tyrosine and proline, 
and is encoded by the STATH gene. It is present in the acquired enamel pellicle because it 
has a strong affinity for the hydroxyapatite structure of enamel. It helps in maintaining 
the re-mineralization capacity of saliva and in keeping its calcium and phosphate content 
balanced (Oppenheim et al., 2007). However, it also presents specific binding sites for 
oral microorganisms like Streptococcus mutans, Actinomyces viscosus, and Candida 
albicans, species that contribute to bacterial colonization of the enamel surface (Dodds et 
al., 2005). Three isoforms have been described for statherins. SV1, which lacks the 
carboxyl terminal, phenyl-alanine; SV2 with a 10-residue amino acid sequence missing in 
the middle of the molecule; and SV3 which arises through posttranslational processing of 
SV2 (Jensen et al., 1991). These isoforms of statherin act as inhibitors of primary as well 
as secondary precipitation of calcium phosphate salts which give them an important 
function in maintaining the enamel homeostasis (Oppenheim et al., 2007). 
Mucin 
Mucins (mainly MUC5B, MUC7) account for the majority of proteins in the 
submandibular and the sublingual glandular secretions. Secretions produced by these 
glans have a viscoelastic consistency attributable to the mucins. Mucins aids in the 
lubrication of the oral mucosa, and the removal of desquamated epithelial cells and food 
debris during swallowing. It also coats the teeth to protect against abrasive forces during 
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the process of mastication, and protects the oral and oesopharyngeal mucosa from acidic 
exposure during vomiting (Dodds et al., 2005), (Dawes et al., 2015). 
Amylase 
Salivary amylase has a molecular weight of 58 kDa and contains 496 amino acids. Lipase 
and α-amylase enzymes are important for starch digestion into maltose, maltotriose, and 
other oligosaccharides. It helps in digesting the starch-containing food debris in the 
mouth. It works optimally at neutral pH, representative of the pH conditions in the oral 
environment, but after swallowing it is inactivated by the acidity of the stomach. The 
salivary glands of the tongue produce lingual lipase, which functions to break down 
triglycerides. In contrast to α-amylase, this enzyme is optimally active at a low pH 
environment as encountered in the stomach (Ruhl, 2012). 
Cystatins: 
Cystatins are composed of 100 to 122 amino acids, and are encoded by CST1, 2, 3, 4 and 
5 genes which produce cystatins SN, SA, C, S, and D, respectively. Cystatin and 
secretory leucocyte protease inhibitor (SLPI) acts as protease inhibitors, inhibiting the 
degradation of other salivary proteins by microbial enzymes and minimizing 
inflammation-associated tissue damage (Dawes et al., 2015). 
Proline-rich proteins (PRPs) 
As indicated in its name, PRP proteins contain high levels of proline (35-40%). The PRPs 
comprise about 70% of the protein content of parotid secretion. There are two types of 
PRPs; acidic and basic PRPs. The acidic PRPs are found in the enamel pellicle and 
exhibit a unique function in having the ability to adsorb to the hydroxyapatite structure of 
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the tooth surface and consequently expose a bacterial binding site for certain oral 
microorganisms (Gibbons and Hay, 1988). Several isoforms of PRPs have been 
described, which are encoded by different genes. The major basic PRPs are encoded by 
four genes, PRB1,2,3 and 4, while acidic PRPs are encoded by two genes, PRH1 and 
PRH2 (Azen et al., 1993). They are in part accountable for the lubricating properties of 
saliva. They have also have been described to bind tannins (Bennick, 1982).  
Other salivary proteins 
Lactoferrin binds to iron which is an essential metal ion required for the growth of some 
pathogenic bacteria. Therefore, lactoferrin is an antimicrobial component of saliva. 
Lysozyme, peroxidase and secretory IgA also all have antibacterial properties. They are 
present in relatively small concentrations compared to some of the other proteins (Ruhl, 
2012). Saliva also contains mammalian cell growth factors such as EGF, VEGF, NGF, 
and FGF, which may help in the reformation of epithelium and the regulation of the 
extracellular matrix (Zelles et al., 1995). More recently, it was discovered that the before 
mentioned histatins have anti-inflammatory effects which facilitate fibroblast migration 
to wound areas and stimulate angiogenesis (Oudhoff et al., 2008). Salivary melatonin acts 
as an indirect antioxidant by eliminating free radicals (Cutando et al., 2007).     
         d) Saliva collection methods 
Saliva can be collected either under stimulated or unstimulated conditions. The most 
common stimulants are paraffin wax, gums, cottons, citric acid, and sour lozenges (Peres 
et al., 2015). 
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There are two types of saliva that can be collected, mixed whole saliva, or pure glandular 
collection. Whole saliva represents the mixed fluid in the oral cavity and contains, 
besides the exocrine salivary secretions, non-exocrine components such as desquamated 
epithelial cells, gingival crevicular fluids, food debris and bacteria. It can be collected by 
drooling, spitting into a tube, suctioning using a saliva ejector or aspirator, or placing a 
pre-weighed absorbent like cotton or gauze on the floor of the mouth. 
Pure secretions from the parotid gland can be collected using a Lashley cup, or a 
modified Carlson Crittenden device, which is a plastic or metal cup with two 
compartments. It consists of a collection tube on one side and a compartment attached to 
a suction device on the other side that is placed over the opening of Stensen’s duct. As for 
the submandibular and sublingual glands collection, a custom-fitted device positioned 
over the orifice of the Wharton’s duct is used. A method of excluding contributions by 
particular secretory glands is by blocking those gland’s orifice separately and using a 
micropipette to collect saliva from the floor of the mouth (Oppenheim, 1970). 
As for minor salivary gland saliva collection, a pipette placed on the inner surface of the 
lips, palate, or buccal mucosa. Secretions can also be collected using an absorbent paper 
strip. The saliva volume can then be measured using a Periotron machine (Proflow 
Incorporated) which measures small volumes of fluids (Navazesh, 1993). 
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2. Enzymatic activities in saliva 
      a) Overview 
Saliva is a mixture made up of diverse salivary and non-salivary constituents. It 
comprises active proteolytic enzymes that act on salivary proteins thereby affecting their 
final structure and function. Vital examples of these proteases are kallikrein-1, and 
human airway trypsin-like protease (HAT), which cause histatin degradation and affect 
their anti-fungal activity against Candida albicans and Cryptococcus neoformans (Sun et 
al. 2009). Collagenase enzymes in saliva, especially the matrix metalloproteinase-8 
(MMP-8) are associated with numerous metabolic activities such as the breakdown of 
extracellular matrix proteins in normal physiological processes, tissue remodeling, wound 
healing, and tooth development. They are also implicated in disease processes such as 
arthritis and tissue destruction observed in periodontitis, implantitis and dental root caries 
(Verstappen and Von den Hoff, 2006).  Besides these proteases of mammalian origin, 
whole saliva contains host of enzymes from bacterial origin (Helmerhorst, et al., 2010). 
Whole saliva also contains multiple protease inhibitors (Sun et al., 2009). A disturbed 
balance between oral proteolytic enzyme activities and inhibitors is thought to at the basis 
of oral pathology and cancer formation (Verstappen and Von den Hoff, 2006). 
      b)  Zymogram assay principle  
Zymography is a valuable method for researching proteolytic activities. It is a 
straightforward, highly sensitive, quantifiable method for the detection of proteolytic 
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enzyme activities. The principle of the method is that proteins are separated by 
polyacrylamide gel electrophoresis under-denaturing, but non-reducing conditions, 
causing the protease enzymes to become reversibly inactive. After electrophoresis, the 
gels are re-natured and the protease enzymes recover their activity. The gel is then 
incubated in an activating buffer, during which the activated proteolytic enzymes digest 
the specific protein substrate incorporated in the gel. After incubation, the gel is stained 
with coommassie blue stain followed by a de-staining step until clear white bands of 
protein degradation appear against blue un-degraded background. The intensity of the 
bands can be quantified by densitometric analysis and image analysis. Within a certain 
range, the higher the band intensity the more proteolytic enzyme activities are present 
(Sun et al., 2009). 
      c) Gluten-degrading enzymes 
Dietary proteins are commonly digested in the human gastrointestinal tract by enzymes 
secreted by the host such as; pepsin, trypsin, chymotrypsin and elastase. However, some 
dietary proteins are difficult to digest and require specific enzymatic cleavage not present 
in the human digestive system to be completely degraded. An example are certain protein 
regions contained in gluten proteins. These proteins are found in many products made of 
wheat, barley and rye and are widely consumed in a variety of cereal, bread, pasta, and 
pastries products throughout the world. Gluten is composed of gliadin and glutenins. 
Both proteins have a high content of proline and glutamine amino acids in their structure. 
The unusual amino acid composition, and the order in which these amino acids occur 
make certain domains highly resistant to degradation by mammalian digestive proteases.  
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In addition, certain domains have the capacity to induce specific intestinal immune 
responses in genetically susceptible patients with celiac disease (Helmerhorst et al., 
2010).  
A number of enzymes have been discovered that have a gluten degrading ability such as; 
prolyl-endopeptidases from microorganisms such as; Sphingomonas capsulata 
Flavobacterium meningosepticum, Myxococcus xanthus (Gass et al., 2005), and by the 
fungus Aspergillus niger (Stepniak et al., 2006). These enzymes, which are discussed in 
detail below, could be of use for the treatment of celiac disease and other gluten-
intolerance disorders. 
 
3. Celiac Disease 
      a) Overview 
Celiac disease is a chronic small intestinal immune-mediated enteropathy precipitated by 
the exposure to dietary gluten in genetically susceptible individuals. Gluten is a protein 
found commonly in the diet, specifically in products made of wheat, rye and barley. 
Celiac disease is considered a complex multifactorial disorder which requires a 
combination of genetic, autoimmune and environmental risk factors to develop 
(Schuppan and Zimmer, 2013). 
Celiac disease can either be present as symptomatic, asymptomatic, or refractory type. It 
has a wide biological, histological and clinical spectrum. Some individuals present with 
the classical gastrointestinal signs and symptoms; others show normal intestinal 
morphology but present with other clinical signs such as skin lesions or neurological 
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disorders. The most severe type is observed in those patients whose symptoms still persist 
even while adhering to a gluten-free diet. This may constitute a different disease 
phenotype and is referred to as refractory celiac disease (Schuppan and Zimmer, 2013). 
The gold standard diagnostic method for celiac disease is an intestinal biopsy to reveal 
villous atrophy. Additional specific and sensitive methods are positive serology for anti-
transglutaminase 2 (anti-TG2) or anti-endomysium antibodies which reportedly have 
high sensitivity (97-100%) and specificity (98-99%) scores (Schuppan et al., 2009).    
     b) Incidence 
One in every 100 individuals in the United States has celiac disease (Schuppan and 
Zimmer, 2013). It is more prevalent in females than males with a 2:1 ratio.  First-degree 
siblings of celiac patients have a 30-fold higher risk of developing the disease. Dizygotic 
twins have a 10% risk of developing the disease in comparison to a 75% risk of 
development in monozygotic twins. This suggests a strong genetic factor, but also that 
there is a non-genetic component to the disease (Gass et al., 2006). Most importantly, 
individuals with a positive HLA-DQ2 and HLA-DQ8 typing are at increased risk of 
developing the disease. This also includes those with diabetes, autoimmune disorders and 
the relatives to celiac disease patients, since they may share some genetic features. Also 
the high consumption of gluten specially in an early age, the premature termination of 
breast feeding, tissue damage by inflammatory mediators, or viral infections are all 
considered possible triggers for celiac disease (Gujral et al., 2012). However, studies 
found even with limited wheat consumption celiac disease can still present in some 
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populations which suggest other environmental or genetic factors involvement (Abadie et 
al., 2011)   
      c) Pathogenesis 
Incompletely digested gluten peptides trigger an autoimmune reaction in genetically 
susceptible individuals who express HLA-DQ2 and HLA-DQ8 MHC class II molecules 
on the intestinal enterocytes (Freeman et al., 2011). Environmental factors such as 
gastrointestinal infections and stress can increase the intestinal mucosal permeability to 
gluten that may aid in the sensitivity to develop CD.   
The immunological response triggered includes antibody production against tissue 
transglutaminase 2 (TG2). TG2 is an enzyme and responsible for de-amidation of the 
neutrally charged glutamine residue in gluten into more negatively charged glutamate 
residues. This modification in the protein facilitates the binding of gluten to antigen 
presenting cells expressing HLA-DQ2 or HLA-DQ8 and subsequently results in the 
activation of the host immune response in certain individuals. 
As part of the immunological process, there is a marked increase in the intraepithelial 
lymphocytes (IEL). Furthermore, CD4 T cells produce pro-inflammatory cytokines such 
as IFN. This inflammatory stage will activate natural killer cells which in turn amplify 
the inflammation and lead to tissue destruction and intestinal villous atrophy (Schuppan 
et al., 2009). 
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      d) Celiac Disease Clinical Characteristics  
There is a wide spectrum of clinical signs and symptoms characteristic for celiac disease 
that differ in children and adults.  The classical signs and symptoms mainly involve 
gastrointestinal manifestations like chronic diarrhea, malabsorption and consequent 
weight loss. However, many patients present with atypical extra-intestinal features like 
anemia, dermatitis herpitiformis, osteoporosis, endocrinopathy, depression and 
neurological problems with no or little gastrointestinal symptoms. This makes celiac 
disease difficult to diagnose. In children, atypical celiac disease is more common, 
presented with growth retardation, excess fat in the feces, abdominal swelling and 
delayed puberty. Untreated symptoms can worsen with time. Furthermore, treated celiac 
disease can lead to refractory celiac disease were patients become unresponsive to a 
gluten free diet and this can eventually lead to gastrointestinal lymphoma (Rubio-Tapia 
and Murray, 2010). 
Histologically, intestinal mucosal biopsies show lymphatic cell infiltration, villous 
atrophy and crypt hyperplasia. In asymptomatic celiac disease, histological findings are 
present without the clinical symptoms and it is only discovered with endoscopy for other 
diseases or serological test screening (Schuppan and Zimmer, 2013).  
Celiac disease is considered more of an autoimmune disease rather than an inflammatory 
disease, due to its association with some of the most common autoimmune diseases, such 
as; type 1 diabetes, autoimmune thyroiditis and rheumatoid disorder. This might be due 
to the fact that both celiac disease and these autoimmune disorders share a common gene 
predisposition (HLA alleles).  
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       e) Treatment of celiac disease 
The only effective treatment currently available for celiac disease is a strict gluten-free 
diet. Since it is extremely difficult to avoid gluten in diet, further understanding of the 
mechanism and pathogenesis of the disease is needed to find better therapeutic options in 
the future (Troncone and Jabri, 2011).  In case of refractory celiac disease, treatment with 
steroids and some immunosuppressive medications can induce mucosal recovery in some 
patients, however, due to the uncommon occurrence of the disease more studies needed 
to evaluate the long term use and side effects (Rubio-Tapia and Murray, 2010). Hence, 
new and alternative treatment approaches is needed to overcome the complications and 
mortality rate associated. 
      f) Gluten-degrading enzyme therapy for celiac disease  
According to the mechanism of development of celiac disease, potential therapeutic 
approaches include; enzymatic break-down of gluten using exogenous proteases (e.g. 
PEPs), specific tTG2 inhibitors, HLA DQ2/8 antigen presenting cells blockers, and 
lowering the intestinal permeability to gluten using inflammatory cytokines blockage 
(Gujral et al., 2012). 
The gluten-degrading prolyl endopeptidases are the most extensively studied enzymatic 
therapies for celiac disease. These enzymes have the ability to degrade proline-rich 
regions in gluten. They have been isolated from various microorganisms; Flavobacterium 
meningosepticum (FM-PEP), Sphingomonas capsulate (SC-PEP) and Myxococcus 
xanthus (MX-PEP). However, these peptidases are not stable at the acidic pH of the 
stomach and are likely degraded before they reach to the intestine where the gluten-
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specific immune response occurs. Stepniak and coworkers identified another PEP from 
Aspergillus niger (AN-PEP) (Stepniak et al., 2006). This enzyme is active over a wide 
range of pH values (2-8) and has been demonstrated to degrade gluten substrates faster 
than other PEPs. Another type of gluten-degrading enzyme has been isolated from barely 
seeds, and is called EP-B2. It is not a prolyl endoprotease, but an enzyme belonging to 
the glutamine-specific cysteine protease family of enzymes. It cleaves peptide bonds 
primarily after glutamine residues (Gass et al., 2006). 
       g) Novel gluten-degrading enzymes from resident oral bacteria 
Of biological interest, the oral cavity has recently been shown by research conducted in 
our laboratory to be rich in gluten-degrading enzymes secreted by natural resident 
microorganisms of the oral cavity (Helmerhorst et al., 2010). The gluten-degrading 
bacteria were identified as Rothia mucilaginous, R. aeria, Actinomyces odontolyticus, 
Streptococcus mittis, Streptococcus sp., Neisseria mucosa and Capnocytophaga 
sputigena (Tian et al., 2017). Their identification was of particular interest, because of the 
natural source of the enzymes in human saliva, and the unique cleavage site specificities 
that these enzymes displayed, setting them apart from the soil bacteria-derived propyl 
endopeptidases. Moreover, the salivary gluten-degrading enzymes were found to have a 
wide pH activity range from 4.0 to 10.0 (Helmerhorst et al., 2010). 
Enzymatic therapeutic approaches for celiac disease may not completely replace the 
gluten-free diet, but may serve as an adjunct therapy and protect patients from the 
occasional ingestion of gluten hidden in the diet (Bethune and Khosla, 2012). Their 
utility as novel therapeutics for the treatment of gluten intolerance disorders is actively 
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being pursued by various research groups, although our laboratory is the only group 
focusing primarily on the enzymes produced by oral bacteria.  
The present study was undertaken to investigate the salivary enzyme activities in a large 
cohort of subjects, and to isolate and identify novel oral bacteria with high gluten-
degrading enzyme activities.  
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CHAPTER TWO: AIMS OF THE STUDY 
 
1. Analyze endogenous enzyme activities in human saliva using casein zymograms 
in a large cohort of donors recruited at the Museum of Science in Boston. 
 
2. Investigate the correlation between the degree of enzyme activity in relation to 
race, age, and gender. 
 
3. To compare casein and gliadin activities in a subset of donors. 
 
4. To isolate novel gluten degrading microbes from the cellular fraction of saliva of 
selected donors. 
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CHAPTER THREE: MATERIALS AND METHODS 
 
1. Saliva collection at the Museum of Science in Boston 
The study, involving the collection of whole saliva samples from subjects visiting the 
Living Laboratory at the Hall of Human Life at the Museum of Science in Boston, was 
approved by the Institutional Review Board (IRB) at Boston University (Protocol number 
H-32808, P.I. Dr. Eva Helmerhorst). The participating adult subjects were consented 
verbally prior to participation. Subjects under 18 years of age were required to be present 
with either their parents or their legal guardians in order to qualify to participate in the 
study. As for the subjects between 12 and 17 years of age, they were consented using a 
separate children consent form in addition to obtaining consent from the parents or their 
legal guardian. Non-identifiable subject information collected from the donors were age, 
race, gender and whether or not they suffer from celiac disease or experience discomfort 
when eating gluten-containing products. 
        
2. Saliva collection procedure 
Saliva collections were carried out for approximately 3-10 min per participating subject. 
At least 1 ml of non-stimulated saliva was collected by asking the donor to expectorate in 
a graduated tube. Immediately after collection the samples were stored in a box 
containing ice packs. At the end of the 4 hr collection time frame at the Museum, the 
samples were transported to Boston University for processing. A total of 769 samples 
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were collected and identified with a specific sample number. A subset of 494 samples 
was analyzed biochemically in this study. 
At BU, the first series of 275 samples were centrifuged and separated into a supernatant 
and a pellet samples. These were not further analyzed in this study. The second series of 
494 samples were aliquoted into 4 x 150 µl of whole saliva. One of the four samples was 
mixed with 150 µl of 80% BHI / 20% glycerol to preserve the viability of the microbes. 
All samples were stored at -80°C until needed. 
 
3.  Casein Zymography 
Pre-cast blue casein 4-16% zymogram gels (Novex by life technologies) were used to 
investigate salivary enzyme activities. One of the 150 µl saliva aliquots was dried using 
Savant SpeedVac® concentrator and re-suspended in 45 µl sample buffer containing 10% 
glycerol, 2% SDS, 0.0025% Bromophenol blue, and 62.5 mM Tris-HCl, pH 6.8. The 
samples were then loaded onto the casein gels and subjected to electrophoresis. A 7 µl 
aliquot of a molecular weight standard was added to the first lane of each gel. The 
running buffer used contained 25 mM Tris-HCl, 192 mM glycine, and 0.1% SDS, pH 8.3. 
Gel electrophoresis was carried out at a constant voltage of 100 V for 3 hr. at 4oC. After 
electrophoresis, enzymatic activities were recovered by washing the gel in a 100 ml 
zymogram renaturing buffer (InVitrogen) for 30 minutes twice at room temperature, 
followed by washing in 100 ml developing buffer (InVitrogen) for 20 minutes 3 times 
and then incubation for 48 hr in a 37oC.  Gels were stained in 40% methanol, 10% acetic 
acid, 0.1% Coomassie brilliant blue R-250 for 24 hr. and then de-stained in the same 
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solution without dye until a good contrast between the bands and the background was 
visible. Proteolytic enzyme activities were visualized as clear white bands of degraded 
proteins. 
 
4. Densitometric analysis of the samples 
Gels were scanned and quantitated using Syngene software (Syngene, Frederick, 
Maryland). The software program determines the pixel intensity in a selected area of the 
gel. Protease activity in each sample is evident from the well-defined colorless bands in 
the gels resulting from the protein digestion. The brighter the area in the original gel the 
higher the intensity number, which indicates a high enzyme activity in that region. 
Manual band quantification was determined by selecting equal size bands from each 
sample within the 75-150 kDa region, and quantitation was based on the raw volume of 
fluorescence emitted from each band. Three different gel backgrounds were also selected 
from each gel and the average background was subtracted from each sample for an 
accurate calculation of the enzyme activity intensity within each band.  
The data collected from each sample were organized in an excel sheet with the assigned 
demographic data and the modified values of band intensity after subtracting the average 
background from each sample. According to the values of the band intensity and after 
manual validation of the results by comparison to the original gel images, the enzyme 
activities in all samples analyzed were organized into high, medium, low, and non-
existent.  
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5.  Comparison of enzyme activities in Casein and Gliadin zymograms 
In our study, the first 273 samples were analyzed using a 10% Gliadin zymogram; the 
remaining 494 samples were analyzed using pre-cast Casein zymogram gels. Pre-cast 
casein gels have the advantage of being commercially available, as opposed to gliadin 
zymogram gels that need to be prepared in the lab. Furthermore, our preliminary studies 
had revealed that casein zymogram gels show identical enzyme patterns as gliadin 
zymogram gels, justifying this approach.  
After the casein zymogram gel analyses were completed, gliadin zymogram gel analysis 
was carried out on a selected number of random samples to validate the similarity in  
casein and gliadin degrading patterns and activity. Gliadin zymogram gel electrophoresis 
was carried as described in (Helmerhorst and Wei, 2014), using gliadin obtained from 
Sigma as the incorporated substrate (Catalog# G3375) at a final concentration of 2 
mg/ml. 
 
6. Bacterial Culture  
Four donor’s saliva samples were chosen for isolating bacterial strains. The selected 
samples of interest showed either high enzyme activity in the 75-150 kDa region, or an 
unusual activity in the low/high MW kDa regions, or both. For the isolation of specific 
bacterial strains, the whole saliva samples were diluted and plated as described below: 
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1: Dilution series and plating on blood agar plates  
The stock sample used for bacteria isolation contained 150 µl of whole saliva and 150 µl 
80% BHI/20% glycerol. A 1:10 serial dilution was prepared by adding 50 µl from this 
stock sample to 450 µl of 1x PBS. From the 10-3, 10 –4, 10 –5, and 10 –6 dilutions, a 50 µl 
aliquot was plated on Brucella Blood Agar plates containing Hemin and Vitamin K. The 
plates were incubated at 37°C for 48 h under aerobic conditions or anaerobic conditions. 
For anaerobic incubation, plates were incubated with GasPak pouches in a sealed jar for 5 
days (Beckton-Dickinson, FRANKLIN lakes, MD).  
2: Cultivation of individual colonies on gluten agar plates  
The bacteria on plates that showed growth were counted and recorded. On average 6 
colonies per saliva sample from the 10-6 dilution were sub-cultured onto gluten agar 
plates to check for their ability to utilize the gluten substrate for growth (Helmerhorst and 
Wei, 2014).  
3: Sub-cultivation of colonies from gluten agar to brucella agar to obtain pure 
cultures 
Strains that grew on gluten agar were subcultured onto blood agar (one strain per plate), 
and subcultured as needed until a visually pure culture was obtained and assessed by 
colony morphology. The bacterial characteristics of the purified bacterial strains, such as 
growth pattern, colony color, morphology, and “stickiness” were recorded for future 
reference. 
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Figure 1: Serial dilution and plating of the saliva samples on Brucella agar plates. 
 Four saliva samples were chosen for bacterial strain isolation. The saliva samples, stored 
in the presence of glycerol, were diluted and plated on Brucella blood agar plates 
containing Hemin and Vitamin K. A 1:10 serial dilution series was prepared and 50 µl 
aliquots from the 10-3, 10-4, 10-5, and 10-6 dilutions were plated. After 48 hrs 
incubation at 37°C under aerobic or anaerobic conditions, bacterial growth was assessed, 
and individual colonies were subcultured to purity.  
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4: Analysis of pure bacteria on a gliadin zymogram  
A cotton swab was used to transfer cells from the blood agar plate to a labeled Eppendorf 
tube containing 80%BHI/20% glycerol for long term preservation of the strain at -80oC. 
Another fresh cotton swab was used to transfer the rest of the colonies from the plate into 
500 ml of sterile PBS. The Optical Density of an aliquot of the suspension diluted in PBS 
(OD<0.8) was determined with a UV Spectrophotometer.  
Bacterial suspension aliquots equivalent to 150 µl OD 5.0 were centrifuged. The 
supernatant was removed and 40 µl of sample buffer was added to the bacterial cell 
pellets. The samples were applied to a custom made 6% gliadin zymogram gel containing 
mixed gliadin as the incorporated substrate. Electrophoresis was carried out at constant 
voltage of 100 V for 3 hr. at 4°C.  The gels were then subjected to renaturing, developing, 
staining and de-staining as described for the casein gels.  
 
7. Statistical methods 
The data from the band intensities measured using the computer software Syngene were 
analyzed statistically for differences in enzyme activities according to race, age and 
gender using the Mann- Whitney U test.  
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CHAPTER FOUR: RESULTS 
1. Demographics of the donors at the Museum of science: 
In total, 769 subject participated in the study, 479 females and 290 males. Based on their 
race categories, there were 618 Caucasians, 41 Asians, 37 Hispanics, 33 African 
American, and 40 reported as mixed race. The age of the participants varied from 7 years 
to 80 years old.  
Six of the total pool of participants reported having either gluten intolerance (Samples 
215, 240, 460), or sensitivity to gluten (Samples 200, 399, 418). Another four subjects 
also reported being on a gluten-free diet due to life style choices or because of 
experiencing discomfort when eating gluten (Samples 263, 309, 310). Only one of the 
participants reported having celiac signs and symptoms with gluten (Sample 415), while 
a few others were still in the process of getting tested for celiac disease (Samples 225, 
272). Overall, the noted incidence of celiac disease and gluten-intolerance was fairly 
consistent with the occurrence of celiac disease and gluten intolerances in the population 
(Sapone et al., 2012). 
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Figure 2: Distribution of the Museum of Science study participants according to 
race.  
They show the highest percentage for the Caucasians at 81%, followed by 5% of Asians, 
5% of Hispanics, 5% of other/mixed race, and 4% of African American. 
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Figure 3: Distribution of the Museum of Science study participants according to 
age.  
Results show the highest percentage for the adults in the age group of 31-54 years old. 
The distribution of participants based in the age groups as follows; the 7-12 years age 
group show 17%, the 13-18 years 10%, 19-30 years 22%, 31-54 years 39%, and the 55-
80 years old group represented 12% of the total participants.  
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Figure 4: Distribution of the Museum of Science study participants according to 
gender 
The data show a higher female participation with an approximate 3:2 ratio compared to 
males. Female participants represented 62%, while male participants represented 38% of 
the number of participants.
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2. Precast casein gel results and densitometric analysis of the different groups 
Of the 769 samples, the last collected 494 samples were analyzed biochemically using 
precast casein zymograms. These gels were used for quantitation of the enzyme activities 
using image analysis software. The zymogram gels were scanned and evaluated for pixel 
intensities in the region of the 75-150 kDa molecular weight. On average the zymogram 
gels showed an intensity value of 1.62 x 108, with a range from 1.37 x 107  to 3.1 x 108 
arbitrary units (AU). 
An example of a casein zymogram gel is shown in Figure 5. The gel show shows 9 
different saliva samples and the enzymatic degradation capabilities.  Protease activity is 
evident by the white band area in different molecular weight regions throughout the gel 
resulting from protein digestion. Quantification of the enzyme intensity is measured 
within the 75-150 kDa region of each sample after scanning the gel using the Syngene 
software.  
According to the obsevations made, the enzyme activities in the samples were organized 
into high, medium, low, and negligible. All 494 samples are shown in the Appendix.  
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           Gel Picture                                                                                        Gel scan  
Figure 5: Zymogram gel of samples (302 – 310)  
showing the enzymatic activity in each sample, in different molecular weight regions. 
The active bands in the 75-150 kDa region (boxed) were densitometrically analyzed by 
scanning the gel using the Syngene software  and comparing the intensity of fluorescence 
from each sample after subtracting the average background intensity. After the analysis 
of all samples was completed, the were organized into groups displaying high, medium, 
low or negligible enzyme activity. 
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3.  Comparison of salivary enzymatic activity among groups based on race, 
age and gender 
The enzyme activity in 494 of the saliva samples was determined with the casein 
zymogram and densitometric analysis approach as outlined above. The data were 
analyzed statistically for differences in enzyme activities according to race, age and 
gender using the Mann- Whitney U test. Based on race, the average enzymatic activity 
among the various race groups was in the order of Other/mixed race > Caucasian > Asian 
> African Amrican > Hispanics. The Other/mixed category show the highest mean band 
intensity of them all with a significant statistical difference compared to the Caucasians 
(P value 0.001), Asians (P value 0.017), Hispanics (P value .00), and African Americans 
(P value 0.012) as shown in Figure 6.  
Regarding the different  age groups, the overall enzymatic activity was in the order of 7-
12 age group > 31-54 > 55-80 > 13-18 > 19-30 year old group (Figure 7).  
As to Gender, no significant statistical differences were found when comparing the 
enzyme activities between males and females in this study when comparing the mean 
band intensities between both groups (P value 0.2), as shown in Figure 8. 
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Figure 6: Comparison of enzyme activities according to race. 
 Salivary enzyme activities determined by pixel intensitities in a pre-case casein 
zymogram gel. Note statistically significant differences among groups, as indicated. The 
highest activities were observed in the Other/ mixed race group. 
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Figure 7 : Comparison of enzyme activities according to age. 
 Results showed highest band intensity in the 7-12 age group with a significant statistical 
difference when compared to the 13-18 age group and the 19-30 group. The lowest 
enzyme activity was recorded for the 19-30 years old age group. 
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Figure 8: Comparison of enzyme activities according to gender.  
With regard to gender, no significant statistical differences were found when comparing 
the mean band intensities between both groups (P value 0.2) 
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4. Comparison of enzyme activities in precast casein and custom made gliadin 
zymogram gels 
The next goal was to investigate the consistency in enzyme patterns observed in precast 
casein and custom-made gliadin zymogram gels. As shown in Figure 8, the enzyme 
activities from the same samples analyzed in both zymograms showed similar pattern of 
protein degradation, validating our earlier observations and indicating that the casein 
zymogram is a useful substitute for the assessment of gluten degradation in human whole 
saliva. 
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A)        Casein Gel                                                           Gliadin Gel 
Original Gels 
  B)  
  
 
 
 
 
 
 
 
 
 
Scanned Gels 
Figure 9: Comparison between precast casein and giadin zymogram gels. 
Zymogram gel analysis of samples: X, Y, Z, A, B, D, L, M, and G. Left, samples 
analyzed on a Casein zymogram gel; right, the same samples analyzed on a  gliadin 
zymogram gel. Top: original gels; bottom: inversed images used for the quantitation of 
activity. 
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5. Active banding patterns and colony morphology characteristics of bacteria 
grown on gluten agar  
The saliva samples selected for further culturing of the bacteria were samples 751, 492, 
529, and 623. Their banding patterns are shown in Figure 10. Their selection was based 
on unique enzymatic activity in the high molecular weight region (75-150 kDa) or the 
low molecular weight region (25-15  kDa). These saliva samples were plated on Brucella 
agar from their glycerol stock and then further subcultured on gluten agar and Brucella 
agar to isolate pure bacterial strains with gluten-degrading activities.  
With this approach, from samples 751, 492, 529 and 623, 9, 5, 4, and 1 pure bacterial 
strains were obtained, respectively. All were analyzed by casein zymography. Colonies 
which demonstrated enzyme activities of interest were chosen for a repeat experiment of 
plating and analysis by gliadin zymography. Information of the colony morphology and 
other characteristics are shown in Appendix 2. 
 
 
 
 
 
 
 
  
  38 
Figure 10: Justification of the selection of the four donor samples 751, 492, 529 and 
623 
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751à high enzyme activity in the 75 kDa region 
no activities in the lower regions. 
 
492à low enzyme activities in the 75-150 kDa 
 high well defined sharp band in the 15-20 kDa 
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529à low enzyme activities in the 75-150 kDa 
 high well defined sharp band in the 15-20 kDa 
region  
623à high enzyme activities in the 75-150 kDa 
 high well defined sharp band in the 15-20 kDa  
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Figure 10: 
 
Sample #751 à expressed high enzyme activity in the 75 kDa region, and no activities 
in the lower regions. 
Sample #492 à expressed high well-defined sharp band in the 20-15 kDa region, and 
very low enzyme activities in the 150-75 kDa region. 
Sample #529 à expressed a well-defined sharp band in the 20-15 kDa region, and low 
enzyme activities in the 150-75 kDa region. 
Sample #623 à expressed high enzyme activity in the 150-75 kDa region and a sharp 
well-defined band in the low 15 kDa region. 
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6.  Enzyme activity testing of the isolated bacteria on 10% Gliadin 
zymogram: 
From samples 751, 492, 529 and 623, 9, 5, 4 and 1 strains were cultured to purity, 
respectively to be further analyzed by gliadin zymography for enzyme activity analysis. 
The bacterial strain names with an “A” in the name indicated that these were originally 
cultured aerobically, whereas those with an “AN” in the name indicates that these were 
cultured anaerobically. The data showed that Sample 492 strain A13 exhibited a sharp 
white band in the 150 kDa molecular weight region.  
Sample 529 strain A1 also exhibited a sharp white band, both 75 kDa and 150 kDa 
regions. Sample 529 strain A9 exhibited a sharp white band in the 75 kDa region.Sample 
623 strain A5 showed high enzymatic activity in the 75-250 kDa region. Sample 751 
strain A8 showed high activity at 75-100 kDa. Sample 751 strain A9 showed a high 
activity in the 150-250 kDa region. Sample 751 strain A10 showed activity in the 150 
kDa region. Some of these strains abive were also cultured anaerobically. The enzyme 
activities under those conditions sometimes differed from activities expressed under 
aerobic conditions. This is shown in more detail in Table 1. 
 
Based on these results obtained, strains 492-A13, 529-A1, 529-A3, 529-A9, 623-A5, 
751-A8, 751-A9, and 751-A10 are considered of highest interest to be further explored in 
future studies. 
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   Gel 1                Gel 2  
                                                                              
The same samples grown under anaerobic conditions:  
 
   Gel 1                Gel 2  
 
 
 
 
 
Figure 11. Casien zymography of individual strains cultured from samples 751, 492, 
529 and 623.  
All strains with an A in the name were cultured aerobically, and with an AN in the name 
were cultured anaerobically. Note differences in MW of the expressed enzymes. 
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Table 1: Bacterial characteristics of the strain isolates: 
Colony  Aerobically Anaerobically MWMW 
enzyme 
Aerobic 
Enzyme 
Activity 
Anaerobic 
Enzyme 
Activity 
Result 
of 1st 
gel 
751 -
A3 
growth(++), 
dark yellow, 
sticky  
tiny(+++), 
whitish-yellow 
75kDa yes/+++ no yes, 
+++ 
751 -
A5 
growth(+), 
yellow, 
sticky 
tiny(+++), 
whitish 
75kDa yes/++ yes/+ yes, 
+++ 
751 -
A8 
growth(++), 
sticky hard, 
stuck on agar 
tiny(+++), 
tiny, whitish 
75kDa yes/+++ yes/+ yes, 
+++ 
751 -
A9 
growth(++), 
star-shaped, 
yellow, non-
sticky 
tiny(++), star-
shaped, rough,  
brown 
150kDa yes/+++ yes/+ yes, ++ 
751 -
A10 
growth(++), 
star-shaped, 
granules, 
sticky 
tiny(++), star-
shaped, rough,  
brown 
125kDa yes/+++ yes/++ yes, ++ 
751 -
A13 
 
 
 
 200kDa    
751 -
A14 
 
 
 
 60kDa    
751 -
A15 
growth (++), 
tiny colonies, 
whitish-
yellow, non-
sticky 
tiny(+++), 
tiny, dark 
yellow 
60kDa no yes/++ yes, ++ 
751 -
AN1 
growth(+++), 
tiny, greyish, 
non-sticky 
tiny(+++), 
tiny, whitish 
75kDa yes/+ yes/+ yes, + 
492-
A7a 
growth(+++), 
light yellow, 
dark-halo, 
non-sticky 
 
tiny(++), tiny, 
whitish 
150kDa no yes/+ yes, ++ 
492-
A7b 
 
growth(+), 
yellow, 
smooth, 
sticky 
tiny(++), 
mixed types of 
colonies 
150kDa yes/+ yes/+ yes, ++ 
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492-
A13 
growth(+++), 
dark yellow, 
non-sticky 
tiny(+), tiny, 
whitish 
250-
75kDa 
yes/+ yes/+ yes, 
+++ 
492-
AN1 
growth(+),  
tiny, whitish, 
non-sticky 
tiny(+),  
whitish 
150kDa no yes/+    (a) yes, + 
     yes/+    (b)  
492-
AN8 
no glycerol no glycerol 70kDa no 
glycerol 
no 
glycerol 
no 
glycerol 
529-A1 growth(+), 
brownish-
yellow, non-
sticky 
tiny(++), 
whitish-yellow 
70kDa yes/+++ yes/+ yes, 
+++ 
529-A2 no glycerol no glycerol 70kDa no 
glycerol 
no 
glycerol 
no 
glycerol 
529-A3 growth(++), 
tiny, 
brownish-
yellow, non-
sticky 
tiny(++), tiny, 
whitish-yellow 
70kDa yes/+++ yes/+ yes, 
+++ 
529-A9 growth(+), 
snowflake-
shaped, 
translucent 
background, 
grown into 
agar, whitish 
yellow, non-
sticky 
tiny(++), 
brown 
40kDa no 
 
 
 
 
yes/+ yes, + 
623-A5 growth(+++), 
whitish, non-
sticky 
tiny(+++), 
tiny, dark 
yellow 
75kDa yes/++ no yes, 
+++ 
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CHAPTER FIVE: DISCUSSION 
Human saliva, the fluid accumulating in the oral cavity, is rich in nutrients, ions and 
resident bacteria. The concept being pursued in our laboratory is that these natural 
inhabitant oral microorganisms aid, or can be exploited to aid, in the initial digestion of 
dietary proteins by secreting enzymes with proteolytic activities.  
Celiac disease, a disease characterized with intestinal immunogenic reactions to gluten in 
the diet, is prevalent, and accounted for by 0.5-2% of the population in the US (Schuppan 
et al., 2009). Up to now, the most effective treatment for celiac disease is to maintain a 
strict gluten-free diet, which is difficult to achieve with the modern diet, expensive, and 
mostly unavailable in many countries (Troncone et al., 2008). One promising therapeutic 
approach is the use of proteolytic enzymes to degrade gluten before the antigenic 
activation in the small intestine occurs, along with the intestinal symptoms. Results from 
our group show that the oral microbiome exhibits a strong proteolytic enzyme activity 
specifically for gliadin peptide degradation. These enzymes are active over a wide pH 
range (pH 4-10), which makes them suitable for gluten digestion throughout the upper 
gastrointestinal tract before such peptides reach the intestinal cells to activate the 
symptoms characteristic of celiac disease (Helmerhorst et al., 2010). Caminero and co-
workers (2014) isolated and studied the gut bacteria involved in gluten digestion and 
found that lactic acid bacteria (LAB), especially Lactobacillus, plays an important role in 
gluten digestion. This bacterial species has a special advantage in being a safe candidate 
to be used as a probiotic therapy in the treatment of celiac disease (Caminero et al., 
2014). Another study by Francavilla also suggested the probiotic potential of lactobacilli 
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strains to hydrolyze gluten peptides during simulated gastrointestinal digestion 
(Francavilla et al., 2017). However, our lab reported that lactobacilli are naturally 
elevated in salivary samples from celiac patients (Tian et al., 2017), and thus the 
beneficial effect of this microbe with regard to epitope elimination remains to be fully 
established.   
 
The present study was carried out to quantitate and analyze the degree of gluten 
degrading enzyme activity in a large number of human saliva samples collected from 
visitors to the Museum of Science in Boston, Massachussetts. Enzyme activities were 
correlated with subject age, race and gender. The Museum of Science was chosen as the 
most suitable venue for conducting the study, and the samples were collected  from the 
cohort of subjects attending the museum and showing an interest to participate in our 
study. The Museum of Science was established in 1864 and is considered one of the 
world’s largest science centers and Boston’s most attended cultural institution. It attracts 
approximately 1.5 million visitors a year through its vibrant programs and 700 interactive 
exhibits. In November 2013, the Hall of Human Life was opened with a 10,000 square 
foot space and 70 interactive dynamic learning experiences that explore the human 
biology, nutrition, and evolution through the different perspective of time, physical 
forces, social interactions, and living organisms. It is in the Hall of Human Life that we 
participated with the Living Laboratory Project for saliva collection. In a few months’ 
time, we were able to collect over 700 samples from a very diverse group of donors. 
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Based on the United States population demographics for 2016, statistics show the 
Massachusetts’ population based on race is as follows; 80% White, 9% Hispanics, 6% 
African American, 5% Asian, and 4% Other which includes; Native Hawaiian, American 
Indian, or mixed races. Based on gender, the distribution is 50% males and 50% females. 
According to these statistics, our study sample with respect to race can be considered 
representative for the Massachusetts population. As for gender, our study shows a higher 
prevalence of females than males with a 3:2 ratio, which could be due to the area of the 
study conducted where children usually attend with their mothers more often. 
In regard to the selected bacteria isolated from our study samples, when compared to 
previous studies by Fernandez-Feo et al., 2013, samples that show high proteolytic 
activity in the 75 kDa region and a characteristic sticky colony morphology can be 
speculated to be a Rothia spp. Rothia spp are natural inhabitant microorganisms in the 
oral cavity that have the ability to cleave the immunogenic part of the gliadin peptides. 
Those that showed lower MW but weak enzyme activity (e.g. strain 529-A8) can be 
speculated to be Actinomyces spp., e.g. A. odontolyticus, which produces an enzyme that 
has previously been shown to have gluten degrading capacity (Fernandez-Feo et al., 
2013). However, the identity of strain 529-A8remains to be resolved and it may represent 
a novel species with as yet unknown gluten-degrading activity. Overall, these naturally 
available oral bacteria with their active gluten degrading enzymes can be isolated and 
potentially used therapeutically as supplemental probiotic medications to aid in the 
digestion of gluten in celiac disease patients. In order to achieve this, these supplemental 
medications need to be active throughout the different pH levels of the human 
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gastrointestinal system and to be checked for the ideal safety dosage without causing 
unnecessary side effects. 
 
Further studies should be conducted to analyze the bacterial strains which showed 
unusual enzymatic activity in relation to gluten degradation. Moreover, samples from 
participants who reported having celiac symptoms or gluten sensitivity/intolerance, and 
those who are selectively on gluten free diet should be analyzed for comparison with the 
average normal saliva. First results in this realm have already been conducted (Tian et al., 
2017), and results of such studies, as well as the introduction of selected strains in 
gnotobiotic mice and monitoring digestion (Caminero et al., 2016) will provide insights 
into the positive role these microorganisms could play with respect to resolving or 
preventing celiac disease symptoms in the future.  
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APPENDIX 1: Gel Pictures Index 
Gel pictures of enzymatic activities of all the samples on precast casein zymogram 
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  49 
            Gel picture            Gel scan  Samples 
 
 
 
 
 
 
(320-328)           
 
 
 
 
 
  
 
(329-337) 
 
 
 
 
 
  
(338-346) 
 
      
(347-355) 
 
 
 
 
 
 
 
 
 
(356-364) 
  50 
  
 
      Gel picture 
          
         
           Gel scan 
 
Samples 
 
 
 
 
(365-373) 
 
 
 
(374-382) 
  
 
(383-391) 
 
 
 
(392-400) 
      
 
(401-409) 
  51 
 
 
 (437-445) 
   
(446-454) 
 
      Gel Picture 
 
            Gel scan 
 
      Samples 
  
 
(410-418) 
  
 
(419-427) 
  
 
(428-436) 
  52 
 
Gel Picture 
 
 
 Gel scan    
 
Samples 
  
 
(455-463) 
  
 
(464-472) 
  
 
(473-481) 
  
 
(482-490) 
 
  
 
(491-499) 
  
  53 
 
Gel Picture 
 
Gel scan    
 
Samples 
      
 
(500-508) 
  
 
(509-517) 
  
 
(518-524) 
  
 
(525-533) 
  
 
(534-542) 
  
  54 
 
        Gel picture 
 
        Gel scan 
 
Samples 
 
  
 
(543-551)   
      
 
(552-559)   
  
 
(560-568)   
  
 
(569-577)   
  
 
 
(578-586)   
  55 
 
Gel Picture 
              
           Gel scan 
 
         Samples 
  
 
(587-595)   
 
  
(596-604) 
 
  
(605-613) 
 
  
(614-622) 
 
  
(623-631) 
  
  56 
  
        Gel picture 
 
      Gel scan 
  
          Samples 
 
 
 
 
 
(632-640) 
 
 
 
 
(641-649) 
  
 
(650-657)   
 
 
 
(658-665)   
  
 
(666-674)   
  57 
Gel picture Gel scan  Samples 
   
 
(675-683)   
  
 
(684-692)   
   
(693-701)  
 
 
 
(702-710)   
 
 
 
(711-719)   
  
  58 
Gel scan Gel picture Samples 
 
  
         (720-728)   
 
 
 
(729-737)   
 
 
 
(738-746)   
   
          (747-755)   
 
 
 
(756-762) 
  59 
 
 
(763-769)   
 
 
 
 
 
 
 
 
 
 
 
 
  
  60 
APPENDIX 2: Bacterial Analysis 
Table 2: bacterial analysis from sample 751 which expressed high enzyme activity in 
the 75 kDa region, and no activities in the lower regions. 
Sample # Type of 
Growth 
A: 
aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Anaerobic 
bacterial 
characteristics 
751 A 1 only 2 colonies on 
BA, discarded 
n/a __ 
751 A 2 no growth, 
discarded 
n/a __ 
751 A 3 growth(++), dark 
yellow, sticky  
yes, +++ growth(++), tiny, 
whitish-yellow, 
non-sticky 
751 A 4 8 colonies, 
discarded 
n/a  __ 
751 A 5 growth(+), 
potential 
contamination, 
yellow, sticky 
yes, +++ growth(++), tiny, 
whitish-
translucent, non-
sticky 
751 A 6 growth(++), 
yellowish, non-
sticky 
no __ 
751 A 7 growth (+++), 
greyish, non-
sticky 
no __ 
751 A 8 growth(++), 
rothea aeria? hard, 
stuck on agar, 
sticky 
yes, +++ growth(++), tiny, 
whitish, non-
sticky 
751 A 9 growth(++), star-
shaped, yellow, 
non-sticky 
yes, ++ growth(++), tiny, 
star-shaped, 
rough, brown, 
non-sticky 
751 A 10 growth (++), 
rothea aeria?  star-
shaped, granules, 
sticky 
yes, ++ growth(++), tiny, 
star-shaped, 
yellow, non-
sticky 
751 A 11 growth (+++), 
tiny, halo, whitish-
yellow, non-sticky 
no __ 
751 A 12 growth (+++), 
tiny, yellow, non-
sticky 
no __ 
751 A 13 growth(+++), tiny, 
dark yellow, non-
sticky 
yes, ++ no growth 
751 A 14 growth (++), tiny 
colonies, whitish-
yellow, non-sticky 
yes, ++ no growth 
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751 A 15 growth (++), tiny 
colonies, whitish-
yellow, non-sticky 
yes, ++ growth(++), tiny, 
dark yellow, non-
sticky 
 
 
 
 
 
 
 
 
 
 
 
 
Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
751 AN 1 growth(+++), 
very minor 
contamination, 
tiny, greyish, 
non-sticky 
yes, + 1 big sticky, 
whitish colony 
growth(++), 
tiny, whitish-
translucent, 
non-sticky 
751 AN 2 growth(+++), 
very tiny, non-
sticky 
no ___ ___ 
751 AN 3 growth(+++), 
medium-sized, 
greyish, non-
sticky 
no ___ ___ 
751 AN 4 no growth, 
discarded 
n/a ___ ___ 
751 AN 5 growth(+++), 
tiny, grey, non-
sticky 
no ___ ___ 
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Table 3: Bacterial analysis from sample 492 which expressed high well defined 
sharp band in the 20-15 kDa region, and very low enzyme activities in the 150-75 
kDa region: 
Sample # Type of 
Growth 
A: aerobically 
An:anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic bacterial 
characteristics 
492 A 1 growth(+++), 
small, whitish 
yellow, non-sticky 
yes, ++ ___ ___ 
492 A 2 growth(+++), light 
yellow, sticky 
yes, ++ ___ ___ 
492 A 3 growth(+++), light 
yellow, dark-halo, 
granules, non-
sticky 
yes, ++ ___ ___ 
492 A 4 growth(+++), light 
yellow, granules, 
sticky 
yes, + ___ ___ 
492 A 5 growth(+++), light 
yellow, dark-halo, 
non-sticky 
no ___ ___ 
492 A 6 growth(+++), light 
yellow, sticky 
no ___ ___ 
492 A 7a growth(+++), light 
yellow, dark-halo, 
non-sticky-
glycerol 1 
yes, ++ ___ growth(++), tiny, 
yellowish,granules,  
non-sticky 
492 A 7b growth(+), yellow, 
smooth, 
sticky(possible 
contaminants?)-
glycerol 2 
yes, ++ ___ growth(+), mixed 
types of colonies, 
small white patches,  
non-sticky 
492 A 8 plate is incubating 
to run gel 
 ___ ___ 
492 A 9 growth(+++), light 
yellow, sticky 
yes, +++ ___ ___ 
492 A 10 growth(++), big, 
light yellow, 
sticky 
 
no ___ ___ 
492 A 11 growth(++), big, 
light yellow, 
sticky 
yes, +++ ___ ___ 
492 A 12 growth(+++), light 
yellow, sticky 
no ___ ___ 
492 A 13 growth(+++), dark 
yellow, non-sticky 
yes, +++ slightly sticky growth(+), tiny, 
whitish, non-sticky 
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Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
492 AN 1 growth(+), tiny, 
stuck into agar, 
whitish-yellow, 
non-sticky 
yes, + yes growth(++), big, 
smooth, white, 
non-sticky 
492 AN 2 growth(+++), tiny, 
whitish-yellow, 
non-
sticky(glycerol 
plate didn't grow) 
no ___ ___ 
492 AN 3 growth(++), tiny, 
yellow, non-sticky 
no ___ ___ 
492 AN 4 growth(+++), tiny, 
light-yellow, non-
sticky(glycerol 
plate didn't grow) 
yes, + ___ ___ 
492 AN 5 growth(++), tiny, 
white, non-
sticky(glycerol 
plate didn't grow) 
no ___ ___ 
492 AN 6 growth(++), tiny, 
white, 
nonsticky(glycerol 
plate didn't grow) 
no ___ ___ 
492 AN 7   ___ ___ 
492 AN 8 growth(++), tiny, 
white, non-
sticky(glycerol 
plate didn't grow) 
yes, ++ no glycerol 
stock 
___ 
492 AN 9 growth(++), 
small, white, non-
sticky 
no ___ ___ 
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Table 4: Bacterial analysis from sample 529 which expressed a well-defined sharp 
band in the 20-15 kDa region, and low enzyme activities in the 150-75 kDa region. 
Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Aerobic bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
529 A 1 growth(+), 
brownish-yellow, 
non-sticky 
yes, +++ ___ growth(++), tiny, 
whitish-yellow, 
non-sticky 
529 A 2 growth(++), 
brownish-yellow, 
non-
sticky(glycerol 
plate didn't grow) 
yes, +++ ___ no glycerol stock 
529 A 3 growth(++), tiny, 
brownish-yellow, 
non-sticky 
yes, +++ ___ ___ 
529 A 4 growth(+++), 
tiny, with halos, 
whitish-yellow, 
non-sticky 
no ___ ___ 
529 A 5 growth(+), 
snowflake-
shaped, whitish-
yellow, non-
sticky 
no ___ ___ 
529 A 6 growth(+++), 
whitish-yellow, 
patches, non-
sticky 
no ___ ___ 
529 A 7 growth(+++), 
light yellow, non-
sticky(glycerol 
plate didn't grow) 
no ___ ___ 
529 A 8 growth(+++), 
whitish yellow, 
sticky 
 
yes, ++ ___ ___ 
529 A 9 growth(+), 
snowflake-
shaped, 
translucent 
background, 
grown into agar, 
whitish yellow, 
non-sticky 
yes, + ___ growth(++ ), tiny, 
translucent, non-
sticky 
529 A 10 growth(++), tiny, 
yellowish, non-
sticky(glycerol 
plate didn't grow) 
no ___ ___ 
529 A 11 growth(+++), 
tiny, granules, 
non-
sticky(glycerol 
plate didn't grow) 
no ___ ___ 
529 A 12 growth(+++),  
yellowish, non-
sticky 
no ___ ___ 
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Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to 
BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
529 AN 1 growth(++), 
whitish-yellow, 
non-sticky 
yes, +++ ___ ___ 
529 AN 2 discarded n/a ___ ___ 
529 AN 3a growth(++),  
dark yellow, 
halo, non-
sticky, 
(glycerol plate 
didn't grow) 
 
yes, +++ ___ ___ 
529 AN 3b growth(++),  
white, non-
sticky, 
(glycerol plate 
didn't grow) 
 ___ ___ 
529 AN 4 discarded n/a ___ ___ 
529 AN 5 growth(+++),  
very tiny, 
paste-like, 
whitish-yellow, 
non-sticky 
yes, + ___ ___ 
529 AN 6 growth(++), 
tiny, brown, 
non-sticky 
yes, +++ ___ ___ 
529 AN 7 discarded n/a ___ ___ 
529 AN 8 growth(++), 
tiny, fuzzy 
look, greenish, 
non-sticky 
no ___ ___ 
529 AN 9 growth(++), 
tiny,  brown, 
non-sticky, 
(glycerol plate 
didn't grow) 
no ___ ___ 
529 AN 10 growth(+++), 
tiny, brownish, 
non-sticky 
no ___ ___ 
529 AN 11 growth(++), 
tiny, greenish, 
non-sticky 
no ___ ___ 
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Table 5: Bacterial analysis from sample 623 which expressed high enzyme activity in 
the 150-75 kDa region and a sharp well defined band in the low 15 kDa region. 
 
Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to 
BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
623 A 1 growth(+++), 
whitish-yellow, 
non-sticky 
no ___ ___ 
623 A 2a growth(+++), 
halo, dark 
yellow, non-
sticky(a)-
glycerol 1 
no ___ ___ 
623 A 2b growth(+++), 
white, non-
sticky(b)-
glycerol 2 
no ___ ___ 
623 A 3 growth(+++), 
whitish, non-
sticky 
no ___ ___ 
623 A 4 growth(+++), 
whitish, non-
sticky 
no ___ ___ 
623 A 5 growth(+++), 
whitish-yellow, 
non-sticky 
yes, +++ yes growth(++) 
yellowish, 
sticky 
     ___ 2  white 
colonies, non-
sticky(not 
enough for gel) 
623 A 6 growth(+++), 
whitish, non-
sticky 
no ___ ___ 
623 A 7 growth(+++), 
whitish, non-
sticky 
yes, + ___ ___ 
623 A 8 growth(+++), 
whitish, sticky 
yes, +++ ___ ___ 
623 A 9 growth(+++), 
whitish, non-
sticky 
yes, + ___ ___ 
623 A 10 growth(++), 
tiny, dark halo, 
whitish-yellow, 
non-sticky 
yes, + ___ ___ 
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Sample # Type of 
Growth 
A: aerobically 
An: 
anaerobically 
Colony # Primary 
bacterial 
characteristics 
from GA to BA 
Enzyme 
activity  
Aerobic 
bacterial 
characteristics 
Anaerobic 
bacterial 
characteristics 
623 AN 1 growth(++), 
tiny, whitish, 
non-sticky 
yes, ++ ___ ___ 
623 AN 2 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 3 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 4 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 5 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 6 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 7 growth(++), 
tiny, whitish, 
non-sticky 
yes, + ___ ___ 
623 AN 8 growth(+), 
snowflakes, 
scattered-big, 
whitish, non-
sticky(glycerol 
plate still 
incubating) 
no ___ ___ 
623 AN 9 growth(++), 
tiny, whitish, 
non-sticky 
yes, + ___ ___ 
623 AN 10 growth(+), tiny, 
whitish-
translucent, 
non-sticky 
no ___ ___ 
623 AN 11 growth(+), tiny, 
whitish, non-
sticky(glycerol 
plate didn't 
grow) 
yes, +++ ___ ___ 
623 AN 12 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
623 AN 13 growth(++), 
tiny, whitish, 
non-sticky 
yes, +++ ___ ___ 
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